LAST UPDATED: Aug 09, 2026
Acknowledgements: Author - Dr Tim Cunliffe.
Acral lentiginous melanoma (ALM) is a rare type of skin cancer primarily affecting the palms, soles, and under the nails (subungual melanoma); the soles are the most commonly affected acral site. Unlike other melanomas, ALM is not strongly linked to sun exposure. ALM is often diagnosed at a later stage, which can lead to a higher risk of morbidity and mortality.
This chapter is set out as follows:
From a clinical perspective, ALM usually presents as a slow growing deceptively banal-looking pigmented macule or patch, hence the term lentiginous. The development of nodular areas within the lesion suggests deeper invasion.
The dermoscopic appearance of melanocytic lesions at acral sites differs to other areas of the body due to the different anatomy. Acral skin consists of a parallel arrangement of the skin surface markings known as the dermatoglyphics, which run straight or in whorls. These surface markings are composed of parallel gyri (ridges) and sulci (furrows). Openings of the eccrine sweat ducts, the acrosyringium, are found in the centre of the ridges.
Once the observer understands the anatomy of skin at acral sites, we can use similar dermoscopic principes to those used for melanocytic lesions at typical body sites, namely:
As with melanoma at any site, there are rule breakers, which at acral sites include (hover over terminologies for description):
Before focusing on ALM, it is important to have a good understand of benign patterns, which are much commoner.
Benign acral naevi tend to have the following dermoscopic features (hover over terminologies for description):
There are several variants of the parallel furrow pattern (PFP), all of which should be well-organised being comprised of thin lines and/or dots. Benign patterns include single and double dotted lines, double lines (one pattern of which has a thin line in the ridge), curved lines in raised dermal naevi, and a partial lattice-like pattern.
Of note, congenital melanocytic naevi (CMN) at acral sites are usually larger, more asymmetric, and have a greater degree of colour variation than acquired acral melanocytic lesions. Additionally, acral CMN may evolve dramatically within the first few months, with clinical changes such as increase in size, thickness, and darkness. Such lesions often require specialist assessment.
Parallel furrow pattern vs parallel ridge pattern - the ink test
It is very important to be able to differentiate between a parallel furrow pattern (PFP), and the parallel ridge pattern (PRP), the most common pattern seen in acral melanoma. A PRP is defined as prominent band-like pigmentation on the ridges of the dermatoglyphic lines. If there is any uncertainty as to whether it is a PFP or PRP, the ink test can help differentiate:
Once an observer can identify a PFP from a PRP this also helps better evaluate the fibrillar pattern, which masks the true dermoscopic pattern.
Assessing the fibrillar pattern
The fibrillar pattern (FP) is detected in 10–20% of plantar naevi, presenting at sites of pressure; it is uncommon on the palms. The FP is characterised by densely packed brownish fibrillar lines arranged in a parallel fashion and crossing the skin markings. Each fibril of the pattern corresponds to a melanin column in the thick cornified layer which is obliquely arranged due to the mechanical pressure from the body weight. In the majority of cases the FP is benign, with pigment originating from the furrows; occasionally FP can be malignant with pigment arising from the ridges.
Differentiating between benign and malignant fibrillar patterns is not always easy; the oblique dermoscopy technique can help the observer.
Oblique dermoscopy refers to resting the dermatoscope on the lesion and then tilting the scope, the lower edge of the scope must remain in contact with the edge of the lesion - looking through the dermatoscope at an oblique angle enables the observer to look underneath the stratum corneum, and may help trace the origins of the pigment, which in the case of a furrow pattern usually suggests a benign lesion. In acral melanoma the pattern does not change to a parallel furrow pattern; however, it is uncommon to identify a parallel ridge pattern. When the observer cannot determine the nature of a FP, six-monthly follow-up is recommended, although if the lesion evolves to greater than 7 mm in diameter, urgent referral is recommended.
Transition patterns
In some benign lesions more than one pattern may be noted, e.g. if a lesion involves both weight-bearing and non-weight bearing areas of skin, or if a lesion curves on to the side of the foot; in such cases the shape of rete ridges transitions from parallel to a reticular pattern.
For the majority of cases of ALM the observer can use the Chaos & Clues algorithm; albeit with some different interpretations, and the EFG rule used at other body sites.
A benign lesion presenting as a parallel ridge pattern is haemorrhage (talon noir). Such lesions should be at sites of pressure / friction and have sharply defined edges, sometimes with red-black globules situated adjacent to the lesion; most importantly the pigment can be removed by pairing of the stratum corneum.
The BRAFF assessment
The BRAAFF score has been shown to significantly improve the diagnostic accuracy of dermoscopy for the diagnosis of ALM. A score of 1 or higher suggests melanoma and warrants further evaluation. A score of 0 or less is less likely to be melanoma, but other factors should still be considered. The BRAAFF score should be calculated as follows:
Malignant features:
B= irregular Blotch: +1 point
R = parallel Ridge pattern: +3 points
A = Asymmetry of structures: +1 point
A = Asymmetry of colours: +1 point
Benign features:
F = parallel Furrow pattern: -1 point
F = Fibrillar pattern: -1 point
Although any digit can be affected, the big toe and thumb are the sites most commonly affected.
There are many other causes of pigmented nails.
Please refer to notes on image rights at bottom of the page with regards to individual image ownership.
Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.
Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.
It is important for the PCDS to build its own image bank, as such we welcome original images from our readers, especially in skin of colour:
Please start typing below the word of any medical term that you do not understand.
The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes